Imagen de la semanaPoliosis secundaria al tratamiento con ipilimumabIpilimumab-induced poliosis
References (0)
Cited by (1)
Adverse Hair Reactions to New Targeted Therapies for Cancer
2019, Actas Dermo-SifiliograficasCitation Excerpt :In the case of ipilimumab, the onset of vitiligo-like hypopigmentation is common (particularly in patients with melanoma), and in initial studies, up to 14% of patients experienced hypopigmentation of hair of the scalp, eyebrows, or eye lashes.18,19 Subsequently, there have been 2 reports of poliosis with this class of drugs, 1 with ipilimumab20 and the other with pembrolizumab.21 However, the reverse effect seems more frequent with PD-1/PD-L1 inhibitors, as a series of 14 patients was recently published of scalp repigmentation after receiving treatment with 1 of these PD-1/PD-L1 agents for nonsmall cell lung cancer (Fig. 3).22
Copyright © 2013 Elsevier España, S.L. All rights reserved.